Wednesday, May 13, 2026 | 08:09 PM ISTहिंदी में पढें
Neuland Laboratories Ltd
Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2025 And; To Recommend Final Dividend If Any For The Financial Year Ended Ma
03:47 PM, 24th Apr 2025
Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2025 and; to recommend final dividend if any for the financial year ended March 31 2025